Interstitial lung diseases are a group of diffuse parenchymal lung disorders associated with
substantial morbidity and mortality. Knowledge achieved in recent years has resulted in the …

Since sarcoidosis was first described more than a century ago, the etiologic determinants
causing this disease remain uncertain. Studies suggest that genetic, host immunologic, and …

Importance The Neurosarcoidosis Consortium Consensus Group, an expert panel of
physicians experienced in the management of patients with sarcoidosis and …

There is evidence that Janus kinase (JAK)–signal transducer and activator of transcription
(STAT) signaling plays a role in the pathogenesis of sarcoidosis. We treated a patient with …

Background Sarcoidosis and granuloma annulare (GA) are cutaneous granulomatous
disorders that can be difficult to treat. There is evidence of underlying Janus kinase (JAK) …

Sarcoidosis is a multisystem disease with tremendous heterogeneity in disease
manifestations, severity, and clinical course that varies among different ethnic and racial …

Thoracic sarcoidosis is the most common form of sarcoidosis, encompassing a
heterogeneous group of patients with a wide range of clinical features and associated …

The diagnosis of sarcoidosis, a systemic granulomatous disease, is based on a compatible
clinical–radiological picture and the histological evidence of noncaseating granulomas …

Rationale: Effective therapeutic interventions for chronic, idiopathic lung diseases remain
elusive. Normalized T-cell function is an important contributor to spontaneous resolution of …

Objective Sarcoidosis is an idiopathic inflammatory disorder that is difficult to treat. There is
accumulating evidence that constitutive activation of Janus kinase–signal transducer and …